Intelligence · Clinical Development
Pipeline search results
Programs matching “amphetamine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 53 pipeline programs matching "amphetamine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
OND-PR002 and MPh-IR
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
Ondansetron
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine-Related Disorders
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
2 trials -
Prazosin
BRIGHT MINDS BIOSCIENCES INC.
Continuous Methamphetamine Abuse
1 trial -
Tyrosine
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine-Related Disorders
1 trial -
Adolescent Methamphetamine Treament (AMT)
BRIGHT MINDS BIOSCIENCES INC.
Behavior and Mental Disorders
1 trial -
Amphetamine
NEUROCRINE BIOSCIENCES INC
Healthy Volunteers
1 trial -
Ibudilast 20mg
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine-dependence
1 trial -
Lobeline
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
Methamphetamine
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Use Disorder
1 trial -
Methamphetamine
BRIGHT MINDS BIOSCIENCES INC.
Stimulant Use
1 trial -
Methamphetamine (Desoxyn®)
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Abuse
1 trial -
Naltrexone and Bupropion SR
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
OROS-MPH
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
Perindopril
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Use Disorder
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Abuse
1 trial -
Pomaglumetad methionil
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Use Disorder
1 trial -
RTI-336
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
Reserpine
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine-Related Disorders
1 trial -
Varenicline, then placebo
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Addiction
1 trial -
d-amphetamine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use Disorder
1 trial -
d-amphetamine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
d-amphetamine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.